Mr. Scott Boyes reports

THE CANADIAN BIOCEUTICAL CORPORATION REACHES MAJOR SUPPLEMENT DEAL WITH MIDDLE EAST CUSTOMER

Through its wholly owned subsidiary CGX LifeSciences Inc., The Canadian Bioceutical Corp. (BCC) has entered into an international conditional sales agreement for its newly acquired FertaMax product line.

BCC's chief marketing officer, Michael Arnkvarn, stated: "We have been working diligently on this project for several weeks. Canadian natural health products are highly valued internationally due to our high-quality production standards and materials control. Our agreement is conditional upon our product being registered with the Ministry of Health of the United Arab Emirates, which simply requires an audit of the Canadian production facilities by one of their authorized inspectors. This audit has been initiated, and we do not foresee any issues with our contract manufacturer, which is already cGMP [current good manufacturing practice] approved by Health Canada."

BCC will issue a subsequent news release to update the marketplace in relation to the status of the aforementioned condition.

"The commercial terms and conditions of the export transaction have been agreed upon by both parties," confirmed Mr. Arnkvarn, "and we expect to deliver the first order during our second fiscal quarter. Confidentiality agreements prevent us from naming the purchaser, but the group currently provides health products to a network of 70,000 pharmacies in several international markets. This customer typically reorders three to five times per year, and we expect that this FertaMax arrangement alone should generate in excess of $1-million in new revenue during the next year."

Scott Boyes, president and chief executive officer of BCC, commented: "Although management is focused on entering into the medical marijuana industry and developing cannabis-based nutraceuticals, FertaMax has broadened our product offerings and provides another positive step to building shareholder value. We are excited that this deal will increase our revenue and should lead to similar export opportunities for this and other products developed by Canadian Bioceutical and its subsidiaries, particularly for CinG-X and for our cannabidiol/Psorberine topical cream currently in development."

FertaMax is a multivitamin supplement designed to assist couples conceive and have healthy pregnancies that result in healthy babies. FertaMax has an all-natural, gender-specific formulation containing the ideal ingredients recommended to bring prospective parents to the peak of their fertility. FertaMax will also help to keep mothers' bodies healthy during pregnancy and assist their bodies to recover after giving birth.

We seek Safe Harbor.